Dennis Ding
Stock Analyst at Jefferies
(0)
# 4869
Out of 5,269 analysts
18
Total ratings
12.50%
Success rate
-27.07%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Crinetics Pharmaceut... | Upgrades: Buy | 55 | 35.84 | 53.46% | 1 | Jan 22, 2025 | |
Inhibikase Therapeut... | Initiates Coverage On: Buy | 8 | 2.31 | 246.32% | 1 | Nov 8, 2024 | |
Assembly Biosciences | Upgrades: Buy | 2 35 | 12.86 | 172.16% | 1 | Sep 20, 2024 | |
Amicus Therapeutics | Initiates Coverage On: Buy | 18 | 9.32 | 93.13% | 1 | Sep 6, 2024 | |
Arbutus Biopharma | Maintains: Strong Buy | 5 7 | 3.4 | 105.88% | 2 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 8 6 | 7.12 | -15.73% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 1 | 0.21 | 138.1% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 216 | 4.8 | 4400% | 1 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 35 22 | 60.66 | -63.73% | 1 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 20.91 | 14.78% | 1 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | n/a | n/a | 1 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 195 52 | n/a | n/a | 2 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 10.45 | -4.31% | 1 | Oct 26, 2021 |